Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -23.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -23.15% | |||
| Cost of Revenue | 0.00% | -17.21% | |||
| Gross Profit | 0.00% | -25.88% | |||
| SG&A Expenses | 0.00% | -16.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -6.75% | |||
| Operating Income | 0.00% | 6.03% | |||
| Income Before Tax | 0.00% | 21.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 21.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 21.48% | |||
| EBIT | 0.00% | 6.03% | |||
| EBITDA | 0.00% | 6.04% | |||
| EPS Basic | 0.00% | 65.60% | |||
| Normalized Basic EPS | 0.00% | 58.60% | |||
| EPS Diluted | 0.00% | 65.60% | |||
| Normalized Diluted EPS | 0.00% | 58.60% | |||
| Average Basic Shares Outstanding | 0.00% | 128.24% | |||
| Average Diluted Shares Outstanding | 0.00% | 128.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||